| Name | Title | Contact Details |
|---|
BBK Healthcare is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Montefiore St. Luke`s Cornwall (MSLC) is a not-for-profit community hospital with campuses in Newburgh and Cornwall, NY. The hospital is dedicated to serving the health care needs of the Hudson Valley and has achieved excellence in the delivery of compassionate and comprehensive health care services. The Joint Commission noted MSLC for excellence in Key Quality Measures in the management of Heart Attack, Heart Failure, Stroke and Surgical Care. MSLC is also recognized as an industry leader in using information technology to improve patient care, by winning the Most Wired Award for the fourth year in a row. In January 2018, MSLC officially became part of the Montefiore Health System to strengthen the delivery of health care locally and enhance access to exceptional specialty care for Hudson Valley residents.
Specialty Medical Sales is a Lewisville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Panoramic Health is the nation`s leading integrated value-based kidney care platform led by physicians. The company is committed to keeping nephrologists independent, relevant, and at the center of patient-care delivery; improving outcomes and slowing disease progression for CKD-ESKD patients. Panoramic Health`s value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world`s largest clinical CKD data warehouses that enable nephrologists to deliver better patient outcomes and value-based care.
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.